A series of novel monobactam inhibitors of human cytomegalovirus (HCMV
) protease has been described that possess a heterocyclic thiomethyl s
ide chain at C-4. Changes to the heterocycle did not significantly cha
nge the inhibitory activity of these compounds in an enzymatic assay,
although improvements in solubility and cell culture activity were not
ed. A number of permutations between C-4 substitutions and N-1 derivat
ives led to the identification of several beta-lactams with antiviral
activity in a plaque reduction assay. N-methyl thiotetrazole-containin
g compounds were found to be the most potent inhibitors in the enzymat
ic assay.